[The value of parameters of iron metabolism in the differential diagnosis of anemias].

As a result of investigations into the diagnostic validity of selected haematologic-morphological and clinical-chemical test factors of iron metabolism in the diagnosis of hypochromic anaemia, the examined test faktora are differently evaluated as individual parameters and in their combination. 1. Haematocrit (PCV) is equal to the determination of haemoglobin concentration as a search parameter.

[The first clinical experience with cryopreserved erythrocyte concentrate].

After a brief illustration of the manufacturing procedure for frozen stored erythrocyte concentrate (GK-EK) the compatibility and transfusion success are assessed by means of clinical and laboratory-chemical parameters. Ensured febrile transfusion responses could not be observed. Indications for GK-EK are given.

[Optimizing the diagnosis of anemia].

The specific value of the erythrocyte parameters MCH and MCV for the differential-diagnostic arrangement of anaemias to the use of the haematological automations of analysis PHA 1/2 is represented. A prerequisite is the precise determination of haemoglobin concentration and erythrocyte number. MCHC has no sufficient discriminatory capacity.

[Comparative study of the efficacy of the DBVCy protocol (daunoblastin, bleomycin, vincristine, cytostasan) and the ABVD protocol in advanced Hodgkin's lymphoma. A prospective inter-clinic study within the framework of the Hauptforschungsrichtung Geschwulsterkrankungen].

In MOPP-resistant patients with Hodgkin-lymphoma stage III B and IV the well known ABVD-protocol was compared with the DBVCy-protocol (daunorubicin, bleomycin, vincristine, cytostasan) in a randomized prospective trial. 73 patients were evaluable, 35 received ABVD, 38 DBVCy. 4 out of 35 (11%) in the ABVD-group and 9 out of 38(24%) in the DBVCy-group reached complete remission.